Mirtazapine relieves postdural puncture headache

Anesthesia and Analgesia

Volumn 107, Issue 1, 2008, Pages 346-

  Sheen, Michael J ^a   Ho, Shung Tai ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MIRTAZAPINE; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; DRUG DERIVATIVE; MIANSERIN;

ADULT; ANTINOCICEPTION; BEDTIME DOSAGE; BRAIN BLOOD VESSEL; CASE REPORT; DRUG HALF LIFE; DRUG INDICATION; EPIDURAL ANESTHESIA; FEMALE; HUMAN; LETTER; MIGRAINE; POSTDURAL PUNCTURE HEADACHE; PRIORITY JOURNAL; PROPHYLAXIS; VASODILATATION; MIDDLE AGED;

FEMALE; HUMANS; MIANSERIN; MIDDLE AGED; POST-DURAL PUNCTURE HEADACHE;

EID: 49849091928     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181771074     Document Type: Letter

References (8)

1. Mokri B. The Monro-Kellie hypothesis: applications in CSF volume depletion. Neurology 2001;56:1746-8
2. Turnbull DK, Shepherd DB. Post-dural puncture headache: pathogenesis, prevention and treatment. Br J Anaesth 2003;91:718-29
3. Bomholt SF, Mikkelsen JD, Blackburn-Munro G. Antinociceptive effects of the antidepressants amitriptyline, du-loxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology 2005;48:252-63
4. Freynhagen R, Vogt J, Lipfert P, Muth-Selbach U. Mirtazapine and its enanti-omers differentially modulate acute thermal nociception in rats. Brain Res Bull 2006;69:168 -73
5. de Boer T. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. Int Clin Psychophar-macol 1995;10(suppl 4):19-23
6. Levy E, Margolese HC. Migraine headache prophylaxis and treatment with low-dose mirtazapine. Int Clin Psycho-pharmacol 2003;18:301-3
7. Schreiber S, Rigai T, Katz Y, Pick C. The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms. Brain Res Bull 2002;58:601-5
8. Timmer CJ, Sitsen JMA, Delbressine LP. Clinical pharmacokinetics of mirtazapine. Clin Pharmacokinet 2000;38:461-74